A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

Summary

The aims of this study are to evaluate: * The safety and tolerability of a single dose of treprostinil given subcutaneously (as an injection just under the skin) * The pharmacokinetic profile (how the body absorbs, breaks down, and gets rid of) of a single subcutaneous dose of a new LY900014 formulation in healthy Japanese participants. The study has two parts. Participants may only enroll in one part.

Timeline

Start

2016-05

Primary completion

2016-07

Completion

2016-07

Drugs

Indications

No indication recorded.